News Search Results
May 05, 2025, 08:00 ET Biocon Biologics Secures Strong Market Access Coverage for Yesintek™ in the United States Covering 100+ Million Lives
international interest rates, change in laws and regulations that apply to the Indian and global biotechnology and pharmaceuticals industries, increasing competition in and the conditions of the Indian and global biotechnology and pharmaceuticals industries, changes in political conditions in India
More news about: Biocon Biologics Ltd.
May 05, 2025, 07:57 ET Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma
YORK, May 5, 2025 /PRNewswire/ -- IGI, a global, fully integrated clinical-stage biotechnology company focused on developing multispecifics™ in oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track
More news about: Ichnos Glenmark Innovation
May 05, 2025, 07:30 ET Palatin Presents Promising Preclinical Data for Melanocortin Agonist PL9588 at ARVO 2025, Highlighting a Dual-Action Glaucoma Therapy
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange
More news about: Palatin Technologies, Inc.
May 05, 2025, 05:45 ET Shareholders that lost money on Sana Biotechnology, Inc.(SANA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
May 5, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA).
More news about: Gross Law Firm
May 05, 2025, 02:25 ET SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. (NASDAQ: SANA) between March 17, 2023 and November 4, 2024, both dates inclusive
More news about: THE ROSEN LAW FIRM, P. A.
May 05, 2025, 01:48 ET BPIPOとDCBがLINK-Jと提携、東京で初の再生医療投資イベントを開催
Corporationは、変性疾患に対する幹細胞治療に力点を置く展示を行いました。同社のHong-Lin Su会長は次のように述べています。「当社の3-in-1ソリューション（多血小板フィブリン、PBMC、成長因子）は、変形性関節症をコントロールするために物理的、化学的な成分を組み合わせたものです。」同様に、Ascension Medical Biotechnology Co., Ltd. は、一貫したGMP製造と臨床試験の実績を強調しました。「私たちは100種類以上のエクソソームを誘導することができ、さまざまな病気をターゲットにしています」と会長のRichard Shieh博士は説明しています。 がん治療分野では、AngenMed
More news about: BPIPO
May 03, 2025, 08:00 ET A Masterpiece in Metal and Light: Groundbreaking Ceremony for the CMU Museum of Fine Arts Marks a Milestone in Taiwan's Architectural History
Chang-Hai Tsai expressed his ambition to extend the university's contributions beyond its achievements in education, medicine, and biotechnology: "Through architecture and art, and through the hand of a master architect, we hope to offer the world a glimpse of Taiwan's
More news about: China Medical University Hospital
May 02, 2025, 16:05 ET Spyre Therapeutics Announces Grants of Inducement Awards
May 2, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization and rational therapeutic combinations to target improved efficacy and convenience
More news about: Spyre Therapeutics, Inc.
May 02, 2025, 10:30 ET Life Science Analytics Market worth $68.81 billion by 2030 11.4% CAGR | MarketsandMarkets™
Pacific is fostering scientific innovation and technological advancement. Furthermore, increased direct investments from pharmaceutical and biotechnology companies in Europe and North America are anticipated to boost the adoption of
More news about: MarketsandMarkets
May 02, 2025, 10:00 ET Lilly to participate in Bank of America Securities 2025 Healthcare Conference
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
May 02, 2025, 09:01 ET University of California, Irvine wins Alamo Cup at Nightwing-Sponsored 2025 National Collegiate Cyber Defense Championship
competitions of its kind, this year's NCCDC tasked competitors with the scenario of managing, operating, and defending the network infrastructure of a biotechnology firm – responding to customers and routine business tasks while fending off attacks from hackers. Akshay Rohatgi,
More news about: Nightwing Group, LLC
May 02, 2025, 07:30 ET Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics
May 2, 2025 /PRNewswire/ -- Darnatein, a subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH), a biotechnology company advancing design-augmented biologics, announced today that it will present scientific data at the 14th International Bone Morphogenetic
More news about: OSR Holdings Inc.
May 02, 2025, 06:30 ET Immunic to Participate in Scientific and Industry Conferences in May
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today
More news about: Immunic, Inc.
May 02, 2025, 05:45 ET Sana Biotechnology, Inc. Class Action: Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA
May 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sana Biotechnology, Inc. ("Sana Biotechnology, Inc." or the "Company") (NASDAQ: SANA) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
May 01, 2025, 21:56 ET DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA) and reminds investors of the May 20, 2025 deadline to seek the
More news about: Faruqi & Faruqi, LLP
May 01, 2025, 18:00 ET Nektar to Announce Financial Results for the First Quarter on Thursday, May 8, 2025, After Close of U.S.-Based Financial Markets
information and a PIN allowing them to access the live call. About Nektar Therapeutics Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases.
More news about: Nektar Therapeutics
May 01, 2025, 17:31 ET EPIDIOLEX Continues to Lead the Way in Cannabinoid-Based Epilepsy Treatment | DelveInsight
Boehringer Ingelheim, Photonamic GmbH, Berg Pharma, Beyond Bio, Genenta Science, Polaris Pharmaceuticals, Telix Pharmaceuticals, Shanghai Simnova Biotechnology, NEONC Technologies, among others.
More news about: DelveInsight Business Research, LLP
May 01, 2025, 16:05 ET BioMarin Reports First Quarter 2025 Results and Reaffirms Full-year Guidance
Conference ID: 4327591 About BioMarin BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The
More news about: BioMarin Pharmaceutical Inc.
May 01, 2025, 16:01 ET AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
May 01, 2025, 12:19 ET Rosalind Franklin University Incubator Company Announces Positive Anti-Fibrotic Effects in Lung Fibrosis Model
NORTH CHICAGO, Ill., May 1, 2025 /PRNewswire/ -- BLR Bio, a biotechnology company in Rosalind Franklin University's
More news about: Rosalind Franklin University of Medicine and Science
May 01, 2025, 09:14 ET David Anderson Named a Top Healthcare Investor of 2025 by GrowthCap
leadership, and ability to navigate the ever-evolving healthcare landscape. Their areas of focus include healthcare software, medical technologies, biotechnology, healthcare services, the connected patient experience, and other related areas. In addition to their investment acumen, these investors have demonstrated
More news about: Ampersand Capital Partners
May 01, 2025, 09:00 ET S&E bio Receives Korea's First Approval for Exosome-Based Therapy Clinical Trial
1, 2025 /PRNewswire/ -- S&E bio Co., Ltd., a biotechnology company specializing in exosomal microRNA-based therapies, has received approval from Korea's Ministry of Food and Drug Safety (MFDS) to initiate
More news about: S&E bio Co., Ltd.
May 01, 2025, 09:00 ET Altesa BioSciences announces Katharine Knobil, M.D. as Chief Medical Officer
Medical Officer. Dr. Knobil, who previously served as the Chief Medical Officer of GSK, brings more than 25 years of experience in pharmaceutical and biotechnology research and development resulting in regulatory approval and launch of blockbuster medicines.
More news about: Altesa Biosciences Inc.
May 01, 2025, 09:00 ET Former USAA CEO Wayne Peacock, and Foot Locker Nonexecutive Chair Dona Young, NACD.DC, to Cochair NACD 2025 Blue Ribbon Commission on Board-CEO Relationship
Maggie Wilderotter — CEO, Grand Reserve Inn; Chairman and CEO, Wilderotter Vineyards; Chair, DocuSign; Director, Costco Wholesale Corporation, Sana Biotechnology, Tanium and Sonoma BiotherapeuticsAbout NACD The National Association of Corporate Directors® (NACD®)
More news about: National Association of Corporate Directors
May 01, 2025, 08:33 ET Mivium Completes $5 Million Funding Round
traditional silicon-based semiconductors in industries such as power electronics, aerospace, telecommunications, AI infrastructure, photonics, and biotechnology. Mivium's team comprises experts in material science and semiconductor manufacturing, driving the company's innovative approach. Media
More news about: Mivium, Inc.